Due to the destruction of pancreatic β-cells lead to an absolute lack of insulin secretion, subcutaneous injection of insulin has been the most important treatment for T1DM (Warshauer et al., 2020). The gene discussed is INS; the disease is type 1 diabetes mellitus.